CTOs on the Move

Asset Health

www.assethealth.com

 
Asset Health is a Troy, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Terry Reilly Health Service

Terry Reilly Health Service is a Nampa, ID-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medical Communication Systems

Medical Communication Systems is a Woburn, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

AdventHealth

AdventHealth is a faith-based, non-profit health care system headquartered in Altamonte Springs, Florida, that operates facilities within nine states across the United States.

Integrated Healthcare Holdings

Integrated Healthcare Holdings, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Integrated Healthcare Holdings, Inc. is based in Santa Ana, CA. You can find more information on Integrated Healthcare Holdings, Inc. at www.ihhioc.com

Accord BioPharma

Foresee is a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange (6576.TWO). Foresee`s R&D efforts are focused in two key areas, namely its unique stabilized injectable formulation (SIF) depot delivery technology with derived drug products targeting specialty markets, and secondly its transformative preclinical and clinical first-in-class NCE programs targeting rare and severe disease areas with high unmet needs. Foresee`s product portfolio includes late stage and early stage programs. CAMCEVI® 42 mg is now approved in the U.S. and under regulatory review in the EU. Additionally, U.S. and EU regulatory submissions are in preparation for CAMCEVI® 21 mg. FP-025 – a highly selective oral MMP-12 inhibitor targeting inflammatory and fibrotic diseases, currently in Phase 2/3 studies, including a Phase 2/3 study for COVID-19 virus-induced acute respiratory distress syndrome (ARDS). FP-045 – a highly selective oral small molecule allosteric activator of ALDH2, a mitochondrial enzyme, for which a Phase 1b/2 study is currently planned for Fanconi Anemia.